Role of Pex19p in the targeting of PMP70 to peroxisome  by Kashiwayama, Yoshinori et al.
.elsevier.com/locate/bbaBiochimica et Biophysica ActaRole of Pex19p in the targeting of PMP70 to peroxisome
Yoshinori Kashiwayama a, Kota Asahina a, Hiroyuki Shibata b, Masashi Morita a, Ania C. Muntau c,
Adelbert A. Roscher c, Ronald J.A. Wanders d, Nobuyuki Shimozawa e,
Masao Sakaguchi f, Hiroaki Kato b,g, Tsuneo Imanaka a,*
a Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University,
2630 Sugitani, Toyama 930-0194, Japan
b Kinetic Crystallography Research Team, Membrane Dynamics Research Group, RIKEN Harima Institute at SPring-8, 1-1-1 Kouto,
Mikazuki-cho, Sayo-gun, Hyogo 679-5148, Japan
c Department of Clinical Chemistry and Biochemical Genetics, Dr. v. Hauner Children’s Hospital, Ludwig-Maximilians-University,
Lindwurmstrasse 4, 80337 Munich, Germany
d Department of Pediatrics, Academic Medical Centre, University of Amsterdam, P. O. Box 22700, 1100DE Amsterdam, The Netherlands
e Division of Genomic Research, Life Science Research Center, Gifu University, Yanagidou 1-1, Gifu 500-8076, Japan
f Graduate School of Life Science, University of Hyogo, Ako, Hyogo 678-1297, Japan
g Department of Structural Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida, Shimoadachi-cho,
Sakyo-ku, Kyoto 606-8501, Japan
Received 25 February 2005; received in revised form 12 October 2005; accepted 13 October 2005
Available online 14 November 2005Abstract
Pex19p is a protein required for the peroxisomal membrane synthesis. The 70-kDa peroxisomal membrane protein (PMP70) is synthesized on
free cytosolic ribosomes and then inserted posttranslationally into peroxisomal membranes. Pex19p has been shown to play an important role in
this process. Using an in vitro translation system, we investigated the role of Pex19p as a chaperone and identified the regions of PMP70 required
for the interaction with Pex19p. When PMP70 was translated in the presence of purified Pex19p, a large part of PMP70 existed as soluble form
and was co-immunoprecipitated with Pex19p. However, in the absence of Pex19p, PMP70 formed aggregates during translation. To identify the
regions that interact with Pex19p, various truncated PMP70 were translated in the presence of Pex19p and subjected to co-immunoprecipitation.
The interaction was markedly reduced by the deletion of the NH2-terminal 61 amino acids or the region around TMD6. Further, we expressed
these deletion constructs of PMP70 in fusion with the green fluorescent protein in CHO cells. Fusion proteins lacking these Pex19p binding sites
did not display any peroxisomal localization. These results suggest that Pex19p binds to PMP70 co-translationally and keeps PMP70 as a proper
conformation for the localization to peroxisome.
D 2005 Elsevier B.V. All rights reserved.Keywords: Peroxisome; Pex19p; Peroxisome membrane protein; ABC protein; PMP701. Introduction
Peroxisomes are organelles bound by a single membrane,
which are present in almost all eukaryotic cells. Peroxisomes
are involved in a variety of metabolic processes including
peroxide-based respiration, oxidative degradation of fatty acids
and purines, and synthesis of plasmalogen and bile acids [1].
Therefore, the defect in peroxisomal biogenesis causes multiple0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2005.10.006
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E-mail address: imanaka@ms.toyama-mpu.ac.jp (T. Imanaka).metabolic dysfunctions such as Zellweger syndrome [2,3]. The
biogenesis of peroxisomes is a complex process requiring
multiple proteins encoded by PEX genes [4–7] with as many
as 32 PEX genes having so far been identified [8]. Almost all
peroxisomal proteins are encoded by nuclear genes, synthe-
sized on free polysomes, and posttranslationally imported into
pre-existing peroxisomes [9]. The majority of matrix proteins
contain either of two peroxisome targeting signals (PTS), PTS1
or PTS2 [10–12]. Proteins containing these signals are
recognized by specific cytosolic receptors, Pex5p and Pex7p
[13,14], and are then imported into the peroxisome matrix by
an ATP-dependent pathway [15,16].1746 (2005) 116 – 128
http://www
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peroxisomal membrane proteins (PMPs). They do not contain a
recognizable PTS1 or PTS2 sequence [17] and their import is
independent of PTS1 or PTS2 receptors [18,19]. Therefore,
PMPs seem to be imported into peroxisomes by a distinct
mechanism by which peroxisomal matrix proteins are
imported. Most PEX genes are required for importing of
peroxisomal matrix proteins but not for peroxisomal membrane
biogenesis. Only cells harboring the mutant genes of PEX3,
PEX16, and PEX19 lack detectable peroxisomal structures
[20–22], indicating that these gene products are involved in the
synthesis of the peroxisomal membrane or the import of PMPs.
Pex19p, the PEX19 gene product, is mainly located in the
cytosol and can also associate with the peroxisomal membrane
[23]. Pex19p has been shown to bind multiple PMPs [23–26],
and the defect of this protein results in degradation and/or
mislocalization of PMPs [19]. Moreover, the mislocalization of
Pex19p to the nucleus leads to the accumulation of PMPs in the
nucleoplasm [23]. From these observations, it is suggested that
Pex19p is able to act as a chaperone for PMPs.
PMP70 is one of the major components of the mammalian
peroxisomal membranes and belongs to the ATP-binding
cassette protein superfamily [27,28]. It consists of 659 amino
acid residues, and the putative topology of PMP70 predicts six
transmembrane segments with NH2- and COOH-terminus
facing the cytoplasm. In the PEX19 mutant cell, PMP70
mostly remained in the cytosol and was degraded rapidly [29].
This finding was interpreted to suggest that the interaction
between Pex19p and PMP70 was important for the targeting of
PMP70. To better understand the role of Pex19p in the
targeting process of PMP70, we have characterized the binding
of Pex19p to various regions of PMP70 using an in vitroTable 1
Oligonucleotide primer sequences used for construction of plasmids
Conctruct name Oligonucleotide Primer (5VY3V)
PMP70(AA.1-659) TTTAAACTCGAGCCGCCATGGCGGCCTT AT
PMP70(AA.62-659) AATTATATTATACTCGAGATGGTGTTTTTCTC
PMP70(AA.175-659) AATTATATTATACTCGAGATGGGGAATCTGG
PMP70(AA.224-659) AATTATATTATACTCGAGATGGCAATTGGAG
PMP70(AA.263-659) AATTATATTATACTCGAGATGGGAGAATATA
PMP70(AA.314-659) AATTATATTATACTCGAGATGGGCTTCATTG
PMP70(AA.341-659) AATTATATTATACTCGAGATGTCTCATCCTCG
PMP70(AA.1-347) TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.1-321) TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.1-271) TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.1-229) TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.1-183) TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.62-271) AATTATATTATACTCGAGATGGTGTTTTTCTC
AATTATATTATAAGCGGCCGCCTACCGAGAA
ABC-me ATATTATAACTCGAGATGCGCGCCCCTTCTG
PMP70(AA.1-659)-GFP TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.1-347)-GFP TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.62-659)-GFP AAATTTCTGCAGGCCATGGTGTTTTTCTCA
PMP70(AA.1-271)-GFP TTTAAACTCGAGCCGCCATGGCGGCCTT AT
PMP70(AA.1-183)-GFP TTTAAACTCGAGCCGCCATGGCGGCCTT A
PMP70(AA.1-144)-GFP TTTAAACTCGAGCCGCCATGGCGGCCTT TT
PMP70(AA.1-122)-GFP TTTAAACTCGAGCCGCCATGGCGGCCTT A
Restriction sites used for directional cloning are underlined (XhoI or PstI in forwa
truncated mutants anneals to downstream of PMP70cDNA, and the PCR product wtranslation system and examined the role of the regions in the
targeting of PMP70 to peroxisomes.2. Materials and methods
2.1. Materials
PRO-MIXi: L-[35S] in vitro cell labeling mix (70% L-[35S]methionine
and 30% L-[35S]cysteine, >37 TBq/mmol) was purchased from Amersham
Biosciences (Piscataway, NJ). PROTEIOSi, a wheat germ cell-free protein
synthesis core kit, was obtained from TOYOBO (Osaka, Japan). Nucleotides
such as ATP, CTP, UTP, and GTP for mRNA synthesis were obtained from
Promega (Madison, WI). The protein G-agarose and molecular weight marker
were from Sigma (St. Louis, MO). pQE30, pEU3-NII and pEGFP-N1 were
obtained from Qiagen (Valencia, CA), TOYOBO (Osaka, Japan), and Clontech
(Palo Alto, CA), respectively. The mouse anti-His G antibody was from
Invitrogen (Carlsbad, CA). Preparation of the antibody against the COOH-
terminal 15 amino acids of rat PMP70 was described in [30]. The anti-rat liver
catalase antibodies were raised in guinea pigs [31].2.2. Plasmid constructions
The plasmid pcDNA3/PEX19, which contains the human cDNA sequence
encoding Pex19p, was described in [32]. From this cDNA, the full-length
Pex19p was excised with BamHI and HindIII and recloned into pQE30 vector
at the corresponding sites to obtain pQE30/PEX19. Different cDNA fragments
of PMP70 were amplified using a full-length human PMP70 cDNA [33] as a
template. The PCR-generated fragment with XhoI and PstI or NotI and BamHI
restriction sites was subcloned in frame into either pEU3-NII or pEGFP-NI
expression vector, respectively. The full-length cDNA of mouse ABC-me with
XhoI and NotI sites was generated by PCR using the ABC-me cDNA in pRc/
CMV vector [34] as a template. The obtained fragment with XhoI and NotI
sites was ligated with pEU3-NII vector. The identity of all subclones was
confirmed by semiautomated sequencing on an ABI 310 DNA sequencer
(Perkin Elmer Life Science, Wellesley, MA). The oligonucleotide primers used
for construction of plasmids are listed in Table 1.GGCTGGCAACTAGAAGGC
AAGGCTCATAC ATGGCTGGCAACTAGAAGGC
ACAACAGAATAGC ATGGCTGGCAACTAGAAGGC
CTCAGGG ATGGCTGGCAACTAGAAGGC
GATATGTTAATTCTCGG ATGGCTGGCAACTAGAAGGC
ATAGTATTATTGCC ATGGCTGGCAACTAGAAGGC
ACATCTCAAGAAG ATGGCTGGCAACTAGAAGGC
ATTATATTATAAGCGGCCGCCTACTTGAGATGTCGAGGATGAGA
ATTATATTATAAGCGGCCGCCTAGGCAATAATACTATCAATGAAGCC
ATTATATTATAAGCGGCCGCCTACCGAGAATTAACATATCTATATTCTCC
ATTATATTATAAGCGGCCGCCTAGCCCTGAGCTCCAATTGC
ATTATATTATAAGCGGCCGCCTAAGCTATTCTGTTGTCCAGATTCCC
AAGGCTCATAC
TTAACATATCTATATTCTCC
CT ATATTATAAGCGGCCGCCTACGCCCGTGCAGGTTCCA
AATTTGGATCCGAGCCGAACTCAACTGTGT
AATTTGGATCCTTGAGATGTCGAGGATGAGAC
AGGCTCATAC AAATTTGGATCCGAGCCGAACTCAACTGTGT
ATTTAGGATCCCGAGAATTAACATATCTATATTCTCCTTC
AATTTGGATCCGCTATTCTGTTGTCCAGATTCC
TAAAGGATCCTTCAAGAAGTTATTAACCAGAGAG
AATTTGGATCCAAATCTTTCCTGCTACGACCAATG
rd primers; NotI orBamHI for reverse primers). Reverse primer for N-terminal
as digested at NotI site originally existed in the vector sequence.
Fig. 1. Overexpression and purification of His-Pex19p. His-Pex19p was
expressed and purified as described under Materials and methods. Lane 1, total
bacterial proteins before IPTG induction; Lane 2, total bacterial proteins after
IPTG induction; Lane 3, soluble proteins after sonication; Lane 4, fusion
proteins (20 Ag) purified by TALON Metal affinity resin.
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The plasmid, pQE30/PEX19 was transfected to competent M15 pREP4 E.
coli cells (Qiagen, Valencia, CA) according to standard procedures. The E. coli
cells harboring pQE30/PEX19 were grown at 37 -C in LB media containing 0.1
mg/ml ampicillin. At a cell density of 0.5 (OD600), protein expression was
induced with 1 mM isopropyl-1-thio-h-d-galactopyranoside (IPTG) for 5 h at
37 -C. The cells were harvested by centrifugation at 4000g for 20 min,
resuspended in 35 ml of the lysis buffer (50 mM Tris–HCl, pH 7.5, 0.3 M
NaCl, 5 mM imidazole, 0.1 mM phenylmethylsulfonylfluoride (PMSF)) and
disrupted 20 times for 20 s in an ice bath by Astrason XL-2020 ultrasonic
processor (Misonix inc., Farmingdale, NY). The lysate was centrifuged at
20,000g for 30 min and NH2-terminal His6 tagged human Pex19p (His-
Pex19p) in the supernatant was immediately applied to 10 ml of TALON Metal
affinity resin (Clontech, Palo Alto, CA) equilibrated with the lysis buffer. After
extensive washing, the His-Pex19p was eluted with the lysis buffer containing
250 mM imidazole. The eluted fractions containing His-Pex19p were dialyzed
against 50 mM Tris–HCl, pH 8.0, 50 mM NaCl, and 10 mM DTT and stored at
80 -C.
2.4. In vitro transcription and translation
The plasmids encoded full-length and truncated PMP70, and ABC-me were
transcribed in vitro using T7 RNA polymerase and the mRNAs synthesized
were isolated by MicroSpin G-25 column (Amersham Biosciences, Piscataway,
NJ). Using the purified mRNA, cell free translation was performed according to
the bilayer method using PROTEIOSi, a wheat germ cell-free protein
synthesis core kit according to the manufacturer’s procedure. In a typical
experiment, mRNAs synthesized above were translated for 24 h at 26 -C in a
300 Al of wheat germ cell-free protein synthesis system containing 50 ACi of
[35S] methionine in the presence or absence of 100 Ag of His-Pex19p. After
translation, the reaction mixture was centrifuged for 20 min at 17,000g and
the supernatant was used for co-immunoprecipitation.
2.5. Co-immunoprecipitation
Translation products (50 Al) were precleaned with an appropriate amount of
protein G-agarose in 200 Al of the binding buffer (20 mM HEPES–KOH, pH
7.5, 110 mM potassium acetate, 5 mM sodium acetate, 2 mM magnesium
acetate, 1 mM EDTA, 0.2% Triton X-100, 10 mM DTT). After this step, the
supernatant was removed and incubated with protein G-agarose beads saturated
with anti-His G antibody. After incubation of the suspensions for 2 h at 4 -C,
the beads were collected by centrifugation and washed five times with 250 Al of
the binding buffer. Immunoprecipitated proteins were analyzed on a 7–15%
SDS-polyacrylamide gradient gel. The gels were dried and the radioactivity
level in the band corresponding to PMP70 was quantified by Fuji BAS 5000
imaging analyzer (Fuji Film, Tokyo, Japan).
2.6. Sucrose density gradient analysis
Translation products (250 Al) were centrifuged at 100,000g for 1 h at 4
-C. The resultant supernatant was mixed with equal amounts of the 2 binding
buffer without 0.2% Triton X-100, and subjected to equilibrium density
centrifugation in a 10 ml linear sucrose gradient (5–30% (w/v)) in a NVT65
rotor (Beckman, Fullerton, CA). The gradient rested on 0.5 ml of 50% (w/v)
sucrose. All solutions contained 20 mM HEPES–KOH, pH 7.5, 110 mM
potassium acetate, 5 mM sodium acetate, 2 mM magnesium acetate, 1 mM
EDTA, 10 mM DTT. Centrifugation was carried out at 165,000g for 4 h at 4
-C. Fractions of approximately 1.0 ml were collected from the bottom of the
tube and the density of each fraction was determined by refractometry.
2.7. Cell culture and transient transfection
CHO-K1 cells were cultured in F12K medium (ICN, Aurora, OH) with
10% fetal bovine serum at 37 -C and 5% CO2. 48 h before transfection, 5103
cells were seeded on a Lab-Teki Chamber Slidei System that mounted
8 chambers on a glass slide (Nalge Nunc, Rochester, NY). All transfectionswere performed using Effecten Transfection Reagent (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. Two days after transfection, the
cells were washed 3 times with phosphate buffered saline (PBS) and fixed for
10 min in 5% paraformaldehyde in PBS for indirect immunofluorescence.
2.8. Indirect immunofluorescence
Immunostaining was performed by essentially the same procedure as
described in [11]. The fixed cells were permeabilized in 0.1% (w/v) Triton X-
100 in PBS for 10 min, washed 3 times with PBS, and incubated with the
primary antibodies for 1 h at room temperature. Primary antibodies used in this
study were rabbit antibody against the COOH-terminal 15 amino acids of rat
PMP70 (1:200) or guinea pig antibody against rat catalase (1:200). Cy3-
conjugated goat anti-rabbit or anti-guinea pig antibody (Amersham Bios-
ciences, Piscataway, NJ) was used to decorate the first antibody. The cells were
mounted in 90% glycerol in 100 mM Tris–HCl (pH 8.0) and the samples were
examined by confocal microscopy (Carl Zeiss LSM510, Jena, Germany).
2.9. Other methods
Protein was assayed as described previously [28]. Western blot analysis was
done using primary antibodies and a secondary antibody, donkey anti-rabbit
IgG antibody conjugated to horseradish peroxidase (Amersham Biosciences,
Piscataway, NJ). Antigen–antibody complex was visualized with ECL + Plus
Western blotting detection reagent (Amersham Biosciences, Piscataway, NJ).
3. Results
3.1. Overexpression and purification of His-Pex19p
NH2-terminal His6 tagged Pex19p was expressed in E. coli
and purified as described under Materials and Methods. As
shown in Fig. 1, the fusion protein was expressed upon IPTG
induction as a major protein, and was exclusively recovered in
a soluble form. His-Pex19p purified from the soluble fraction
was >90% pure as judged by SDS-PAGE (lane 4).
Fig. 3. Co-translational interaction between PMP70 and Pex19p. (A) 35S-
labeled PMP70 translated in the presence of 100 Ag of His-Pex19p (lanes 1–3)
was separated into the soluble and insoluble fractions by the centrifugation of
17,000g for 20 min at 4 -C. In the case that PMP70 was translated in the
absence of His-Pex19p (lanes 4–6), after translation, synthesized PMP70 was
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In this study, we used wheat germ lysate instead of
reticulocyte lysate for the in vitro protein synthesis system
since wheat germ does not seem to contain functional Pex19p
in mammalian cells. First, we synthesized mRNA of human
PMP70 and translated it in a wheat germ cell-free protein
synthesis system. As shown in Fig. 2, a polypeptide with
molecular mass of 70 kDa was detected in the translation
product (lane 2). The polypeptide was confirmed as a
translation product derived from PMP70 mRNA by the
immunoblot analysis with antibody against the COOH-terminal
15 amino acids of PMP70 (lane 4). Densitometric analysis
using bovine serum albumin (BSA) as a standard allowed us to
estimate that ¨5 Ag of PMP70 was expressed in a 300 Al of
translation products during 24 h at 26 -C incubation (data not
shown).
3.3. Co-translational interaction between PMP70 and Pex19p
To study the interaction between PMP70 and Pex19p, we
added purified His-Pex19p in the translation system before or
after translation of PMP70 mRNA and examined the interac-
tion of Pex19p with PMP70 by co-immunoprecipitation using
anti-His G antibody. Addition of His-Pex19p showed no effect
on the translation of PMP70 mRNA in this translation system.
When PMP70 was translated in the presence of His-Pex19p,
about 75% of PMP70 was recovered in the supernatant fraction
after centrifugation at 17,000g for 20 min and most of the
PMP70 in the supernatant fraction was co-precipitated with
Pex19p (Fig. 3A, lanes 1–3). In contrast, when we added His-Fig. 2. In vitro synthesis of PMP70. PMP70 (AA.1–659) was synthesized from
a cDNA by in vitro transcription and translation in a wheat germ cell-free
protein synthesis system as described in Materials and methods. Lanes 1 and 2,
Coomassie Brilliant Blue staining. Lanes 3 and 4, immunoblot with anti-
PMP70 COOH-terminal antibody. The samples are as followed: translation
product in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of PMP70
mRNA.
incubated with 100 Ag of His-Pex19p for 2 h at 26 -C, followed by separation
into the soluble and insoluble fractions. Equivalent portions of the total (lanes 1
and 4) and the soluble (lanes 2 and 5) fractions were separated by SDS-PAGE.
Equivalent portions of the soluble fractions were further subjected to co-
immunoprecipitation with anti-His G antibody (lanes 3 and 6). (B) A portion of
each fraction obtained in A was separated by SDS-PAGE and subjected to
immunoblot analysis with anti-His G antibody.Pex19p after translation of PMP70, only 25% of PMP70 was
recovered in the supernatant fraction and only a small amount
of PMP70 in the fraction was co-precipitated with Pex19p
(lanes 4–6). Under the same experimental conditions, His-
Pex19p itself existed in the supernatant fractions (Fig. 3B).
These results suggest that Pex19p interacts with PMP70 co-
translationally and keeps PMP70 in a soluble form.
3.4. Solubilization of in vitro translated PMP70 with Pex19p
In the absence of Pex19p, about 75% of in vitro translated
PMP70 was recovered in insoluble fraction, suggesting that
PMP70 can aggregate. Therefore, we examined the effect of
Pex19p to solubilize PMP70 using different concentration of
Pex19p. As shown in Fig. 4, Pex19p improved the recovery of
PMP70 in the supernatant fraction dose-dependently. In the
presence of 100 Ag of Pex19p, about 75% of PMP70 was
detected in the supernatant fraction. The PMP70 still remained
at the supernatant fraction after centrifugation at 100,000g for
Fig. 4. Solubilization of PMP70 with Pex19p. (A) PMP70 was translated in
vitro in the presence of [35S] methionine and various amounts of Pex19p. These
translation products (T) were separated into the soluble (S) and pellet (P)
fractions by the centrifugation of 17,000g for 20 min at 4 -C. Equivalent
portions of these fractions were analyzed by SDS-PAGE followed by
autoradiography. (B) The amount of soluble and insoluble PMP70 in panel A
were quantified by Fuji BAS 5000 imaging analyzer, and the relative ratio of
soluble and insoluble PMP70 was calculated. The open circles show the
amount of PMP70 in soluble fraction and the closed circles show the amount in
insoluble fraction.
Fig. 5. Specificity of Pex19p for PMP70. (A) ABC-me was translated and
labeled with [35S] methionine in the absence (lanes 1–3) or presence (lanes 4–
6) of 100 Ag of His-Pex19p. These translation products (T) were separated into
the soluble (S) and pellet (P) fractions by the centrifugation of 17,000g for 20
min at 4 -C. Equivalent portions of these fractions were separated by SDS
PAGE followed by autoradiography. The soluble fraction obtained in the
presence of Pex19p was further subjected to co-immunoprecipitation with anti
His G antibody (lanes 7 and 8). (B) ABC-me and PMP70 were co-translated in
the absence (lanes 1–3) or presence (lanes 4–6) of 100 Ag of His-Pex19p
Equivalent portions of the soluble (S) and pellet (P) fractions prepared as
described in A were analyzed by SDS-PAGE (5–10% acrylamide gels instead
of usual 7–15% gels). The soluble fraction obtained in the presence of Pex19p
was further analyzed by the co-immunoprecipitation with anti-His G antibody
(lanes 7 and 8). (C) The relative ratio of soluble ABC-me (open bars) and
PMP70 (closed bars) in B was calculated by Fuji BAS 5000 imaging analyzer
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form in conjugation with Pex19p.
To examine the specificity of Pex19p for PMP70, ABC-
me, a mitochondrial ABC protein which possesses 6
transmembrane domains (TMDs) like PMP70, was translated
in the absence or presence of 100 Ag of Pex19p. In the
absence of Pex19p, only 10% of ABC-me was recovered in
the soluble fraction. Even in the presence of Pex19p, ABC-me
was not solubilized efficiently and only 15% of ABC-me was
recovered in the soluble fraction (Fig. 5A). The amount was
less than that of PMP70 in the absence of Pex19p, and ABC-
me in the soluble fraction was not co-immunoprecipitated
with Pex19p. Furthermore, when ABC-me and PMP70
mRNAs were co-translated either in the absence or presence
of Pex19p, almost the same amount of ABC-me and PMP70
was expressed in each condition. Under the conditions,
PMP70 was preferentially solubilized by Pex19p and only
PMP70 was co-immunoprecipitated with Pex19p from the
soluble fraction (Fig. 5B and C). The solubility of PMP70 in
the presence of Pex19p was decreased by the co-expression
with ABC-me (Fig. 4 vs. Fig. 5B). PMP70 might be
associated with the aggregation of ABC-me under the
condition. In addition, BSA instead of Pex19p was added to
the translation system of PMP70 since BSA is well known to
solubilize hydrophobic polypeptides. Some improvement ofthe solubilization was observed. 30, 40, and 45% of PMP70
was recovered in the soluble fraction in the presence of 20,
50, and 100 Ag of BSA, respectively. However, PMP70 was
not co-immunoprecipitated with anti-BSA antibody and, both
in the presence or absence of BSA, almost the same amount
of PMP70 was solubilized by Pex19p and the amount of-
-
.
.
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not interfered by the presence of BSA (date not shown). These
data strongly suggest that Pex19p preferentially interacts with
PMP70 and solubilizes it efficiently.
3.5. Stoichiometry for the binding of PMP70 to Pex19p
To analyze the stoichiometry of Pex19p to PMP70 in the
complex, we translated PMP70 in the presence of 100 Ag of
His-Pex19p and the molecular mass of the complex in the
soluble fraction was examined by the sucrose density gradient
centrifugation. As shown in Fig. 6A, PMP70 was recovered in
the fractions 1–2 and 7, which corresponded to an approximate
molecular mass of >400 kDa and 100 kDa, respectively. His-
Pex19p was recovered mainly in the fractions 9–11, which
corresponded to a monomeric form of His-Pex19p (34 kDa).
The different distribution between Pex19p and PMP70 seems
to be reasonable since excess amount of His-Pex19p (¨40
times as much as PMP70) was included in the translation
product of PMP70. However, a small part of Pex19p was
detected in the fraction 7. Under longer exposure, Pex19p wasFig. 6. Sucrose gradient centrifugation of PMP70–Pex19p complex. (A)
Translation product was centrifuged at 100,000g for 1h at 4 -C. The resultant
supernatant was loaded on the sucrose gradient (See Materials and methods).
After centrifugation, 11 fractions were collected from the bottom of the tube.
Aliquots of each fraction were subjected to SDS-PAGE and immunoblot
analysis was performed using anti-PMP70 COOH-terminal antibody (upper
panel) and anti-His G antibody (lower panel). The molecular mass of PMP70–
Pex19p complex was calculated by referring to the molecular weights of
standard proteins, carbonic anhydrase (29 kDa), bovine serum albumin (66
kDa), alcohol dehydrogenase (150 kDa), h-amylase (200 kDa) and apoferritin
(443 kDa), respectively. Lane T, PMP70 or His-Pex19p in the soluble fraction
after centrifugation at 100,000g for 1h at 4 -C. (B) Fractions 1 and 7 in A
were subjected to immunoprecipitation with anti-His G antibody. The
immunoprecipitated proteins were then analyzed by immunoblotting using
anti-PMP70 COOH-terminal antibody (upper panel) and anti-His G antibody
(lower panel).also detected in fraction 6 (data not shown). Indeed, Pex19p
was immunoprecipitated from fraction 7, and PMP70 was co-
purified with Pex19p (Fig. 6B). Considering the molecular
mass of PMP70 (70 kDa) and Pex19p (34 kDa), one molecule
of Pex19p seems to associate with one molecule of PMP70 in
the fractions. On the other hand, Pex19p was not precipitated
from fraction 1. As a control experiment, PMP70 translated
without His-Pex19p was sedimented in fraction 1 under the
same condition (data not shown). These results suggest that
PMP70 in the fractions 1 and 2 exist as a large aggregate
without Pex19p.
3.6. Identification of Pex19p interaction sites of PMP70
To identify the regions of PMP70 that are required for the
interaction with Pex19p, we constructed various NH2-terminal
or COOH-terminal truncated PMP70s as shown in Figs. 7A
and 8A based on putative topology of PMP70 [35]. First, the
PMP70 cDNAs encoding full-length and NH2-terminal trun-
cated PMP70 were transcribed with T7 RNA polymerase and
the transcripts were translated in vitro in a wheat germ protein
synthesis system in the presence of [35S] methionine and His-
Pex19p, and soluble fractions were prepared by the centrifu-
gation. 35S-labeled polypeptides, with expected molecular
masses, and several smaller polypeptides were detected (Fig.
7B). Taking the intensity of the labeled band and the number of
methionine and cysteine residues of each deletion construct
into consideration, we estimated that the amount of the major
translation product from each construct was almost the same.
They were immunoprecipitated with antibody against COOH-
terminal 15 amino acids of PMP70 (data not shown). Assuming
the band corresponding to the highest molecular size of PMP70
in each lane is a translation product from the first methionine
residue, some major translation products, PMP70 (AA.224–
659, 263–659, 314–659, and 341–659), seem to be slightly
proteolytically processed in the NH2-terminal regions or
translated from internal methionine residues in the PMP70
cDNAs (Fig. 7B).
Using these translation products, the PMP70s were co-
immunoprecipitated using anti-His G antibody. 35S-labeled
PMP70 (AA.1–659) was precipitated with the antibody. In
same cases, 35S-labeled PMP70 (AA.1–659) existed as very
close doublet bands (Figs. 7B and 8B), but they were
immunoprecipitated with almost the same efficiency. PMP70
(AA.62–659) was also immunoprecipitated, but the amount of
immunoprecipitable PMP70 was reduced and the efficiency
decreased to ¨40% compared with that of full-length PMP70
(Fig. 7C). Similar reduced efficiency was obtained in the cases
of PMP70 (AA.175–659, 224–659, and 263–659). In PMP70
(AA.314–659) and PMP70 (AA.341–659), the efficiency
further decreased to less than 10% and 5% of full-length
PMP70, respectively. These results suggest that NH2-terminal
61 amino acids and the region around TMD5 are required for
efficient interaction of PMP70 and Pex19p, but COOH-terminal
half of PMP70 including TMD6 (AA.314–659), is not.
In the translation products of COOH-terminal truncations of
PMP70, each PMP70 showed clearly two bands (Fig. 8B). The
Fig. 8. Binding of Pex19p to COOH-terminal truncated PMP70. (A) Schematic
drawing of the COOH-terminal truncated PMP70 constructs. Black boxes
represent the position of the six putative TMDs. (B) COOH-terminal truncated
PMP70s were translated and labeled with [35S]methionine in the presence o
His-Pex19p. After centrifugation at 17,000g for 20 min at 4 -C, PMP70s in
the supernatant fraction were subjected to immunoprecipitation using anti-His
G antibody. Co-purified PMP70s were analyzed by SDS-PAGE followed by
autoradiography. (C) The relative bound percentage was expressed as a ratio o
the bound percentage of each mutant with that of full-length PMP70.
Fig. 7. Binding of Pex19p to NH2-terminal truncated PMP70. (A) Schematic
drawing of the NH2-terminal truncated PMP70 constructs. Black boxes
represent the position of the six putative TMDs. (B) NH2-terminal truncated
PMP70s were translated and labeled with [35S] methionine in the presence of
His-Pex19p. After centrifugation at 17,000g for 20 min at 4 -C, PMP70s in
the supernatant fractions were subjected to immunoprecipitation using anti-His
G antibody. Co-purified PMP70s were analyzed by SDS-PAGE followed by
autoradiography. (C) The radioactivity of co-purified PMP70s shown in B was
measured by Fuji BAS 5000 imaging analyzer, and the relative bound
percentage was expressed as a ratio of the bound percentage of each mutant
with that of full-length PMP70.
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each lane was almost the same (approximately 2–3 kDa),
suggesting the lower band is a polypeptide truncated about 20–
30 amino acids from NH2-terminal of PMP70. Full-length of
PMP70 also showed two bands. Two polypeptides of PMP70
(AA.1–347) lacking COOH-terminal half of PMP70 were co-
immunoprecipitated essentially at the same efficiency and the
immunoprecipitable efficiency of the polypeptides were
reduced by only 20% of full-length PMP70 (Fig. 8C). In
contrast, the deletion of amino acid 322–659 including TMD6decreased the efficiency to 40% compared with full-length
PMP70. Additional deletion of TMD5 and TMD4, PMP70
(AA.1–271 and 1–229), did not decrease the efficiency, and
the deletion of TMD3, PMP70 (AA.1–183), slightly decreased
the efficiency compared to PMP70 (AA.1–347). These results
also suggest that TMD6 but not COOH-terminal half of
PMP70 is required for efficient interaction between PMP70
and Pex19p.
To confirm that the regions around the NH2-terminal 61
amino acids, and TMD5 and 6 of PMP70 are important for the
interaction with Pex19p, we translated various constructs
containing these regions in fusion with E. coli dihydrofolatef
f
Fig. 10. Binding of Pex19p to PMP70 lacking NH2-terminal 61 amino acids
and TMD 5 and 6. (A) Full-length and truncated PMP70s were translated and
labeled with [35S] methionine in the presence of His-Pex19p. After
centrifugation at 17,000g for 20 min at 4 -C, the PMP70s in the supernatant
fraction were subjected to immunoprecipitation using anti-His G antibody. Co-
purified PMP70s were analyzed by SDS-PAGE followed by autoradiography.
(B) The relative bound percentage was expressed as a ratio of the bound
percentage of each mutant with that of full-length PMP70.
Fig. 9. Binding of Pex19p to PMP70/DHFR chimera. (A) E. coli DHFR or its
fusion proteins with either or both of NH2-terminal 61 amino acids or TMD5
and 6 of PMP70 were translated and labeled with [35S] methionine in the
presence of His-Pex19p. After centrifugation at 17,000g for 20 min at 4 -C,
soluble proteins were subjected to immunoprecipitation using anti-His G
antibody. Co-purified proteins were analyzed by SDS-PAGE followed by
autoradiography. (B) The relative bound percentage was expressed as a ratio of
the bound percentage of each fusion protein with that of full-length PMP70.
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(Fig. 9). DHFR did not interact with Pex19p at all. However,
chimeric proteins containing the NH2-terminal first 61 amino
acids or TMD5 and 6 of PMP70 showed the interaction with
Pex19p. Furthermore, the fusion protein containing the both
regions (NH2-terminal first 61 amino acids and COOH-
terminal TMD5 and 6) increased the efficiency of theinteraction. On the other hand, to examine whether TMD1–4
is important for the efficient interaction of PMP70 and Pex19p,
PMP70 (AA.62–271) lacking both NH2-terminal 61 amino
acids and TMD5 and 6, was translated and examined the
interaction with Pex19p. As shown in Fig. 10, PMP70
(AA.62–271) was immunoprecipitated with anti-His G anti-
body, but the efficiency was ¨40% of full-length PMP70 and
was comparable to that of PMP70 (AA.62–659) and PMP70
(AA.1–321). Therefore, the TMD1–4 still has the ability to
bind Pex19p, but both NH2-terminal 61 amino acids as well as
TMD5 and 6 are required for the efficient binding to Pex19p.
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Fig. 11. Intracellular localization of PMP70–GFP fusion proteins. (A) Constructs of PMP70 truncation mutants and their peroxisomal localization. The ellipse shows
the position of GFP, black boxes represent the position of the six putative TMDs. (B, C) GFP, GFP-SKL and PMP70–GFP fusion proteins were expressed in CHO
cells. The cellular distribution of the fusion proteins, except for PMP70 (AA.1–659)-GFP and PMP70 (AA.62–659)-GFP, was compared with the localization of the
endogenous PMP70 detected by immunofluorescence staining with anti-PMP70 COOH-terminal antibody. In the case of PMP70 (AA.1–659)-GFP and PMP70
(AA.62–659)-GFP, their intracellular localization was compared with the peroxisomal marker enzyme catalase detected by immunofluorescence staining with anti-
catalase antibody. Peroxisomal staining pattern was shown on the left, EGFP fluorescence in the center, and superimposition of both stains on the right.
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the targeting process of PMP70 to peroxisome
To determine the role of Pex19p, we expressed various
deletion constructs of PMP70 in fusion with the NH2-terminus
of green fluorescent protein (GFP) in CHO cells, and examined
their intracellular localization by immunofluorescence (Fig.
11A). GFP was found in the cytosol and did not display any
peroxisomal localization. However, GFP-SKL that contained
PTS1 was directed to peroxisomes (Fig. 11B). Also, PMP70
(AA.1–659)-GFP and PMP70 (AA.1–347)-GFPwere localized
to peroxisomes. However, fusion proteins lacking the Pex19p
interaction sites corresponding to the NH2-terminal first 61
amino acids or TMD5 and 6, as in PMP70 (AA.62–659)-GFP
and PMP70 (AA.1–271)-GFP, were exclusively mislocalized in
the cytosol. These results suggest that the regions interacting
with Pex19p are important for proper targeting of PMP70.
Concerning the candidate region(s) responsible for the
targeting of PMP70 to the peroxisomal membranes, we
constructed further COOH-terminal deletions of PMP70-GFP
(Fig. 11C). The truncated fusion proteins, PMP70 (AA.1–
183)-GFP and PMP70 (AA.1–144)-GFP, reappeared the
peroxisomal localization (see Discussion). However, PMP70
(AA.1–122)-GFP was diffused to the cytosol and was not
localized to peroxisomes. These results suggest that the
putative peroxisomal targeting signal of PMP70 is just around
TMD2 and does not overlap the Pex19p interaction site at
NH2-terminal 61 amino acids. Around TMD2, there is the
positively charged basic amino acid cluster which is suggested
to be the peroxisomal targeting motif of other PMPs.4. Discussion
Pex19p is essential for the early steps of peroxisome
biogenesis and most likely involved in peroxisomal membrane
synthesis. Although its precise function is still unknown, it
seems to act as a chaperone-like protein for peroxisomal
targeting and insertion of various PMPs [21–25]. To better
understand the role of Pex19p in the targeting process of PMPs,
we expressed human PMP70 and its truncated mutants in
wheat germ in vitro protein synthesis systems, and investigated
the interaction between PMP70 and Pex19p.
First, in this study, we found that Pex19p bound to PMP70
co-translationally and improved its solubility (Figs. 3 and 4).
The interaction of Pex19p and PMP70 showed specificity, and
Pex19p did not interact with ABC-me, a mitochondrial
membrane protein (Fig. 5). The complex of Pex19p and
PMP70 showed the molecular mass of ¨100 kDa (Fig. 6),
suggesting that one molecule of Pex19p binds to one molecule
of PMP70. As PMP70 is a hydrophobic integral membrane
protein, PMP70 must require Pex19p to keep it in a soluble
form. In addition, newly synthesized PMP70 is known to stay
in the cytosol and be rapidly degraded in CHO cells harboring
mutant PEX19 gene [29]. Very recently PMP34 has also
shown to be degraded rapidly in Pex19p deficient human
fibroblast [36]. Therefore, the interaction of PMP70 with
Pex19p is also required for the proper conformation of PMP70
to target it to peroxisomes. PMP70 might be misfolded
without Pex19p in the cytosol and degraded by proteasomes,
which participate in the degradation of many misfolded
proteins [37,38].
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associate with peroxisomal membranes, therefore the cellular
site where Pex19p functions is complicated. Snyder et al. [24]
assumed Pex19p interacts with preexisting PMPs on the
peroxisomal membrane. Gould and coworkers [23,36], how-
ever, concluded Pex19p interacts with newly synthesized PMPs
in cytosol. Our data is consistent with the latter case because
our co-immunoprecipitation experiments were performed with
lysate, which lacks peroxisomal membranes. The solubilization
effect of Pex19p strongly suggests its chaperone-like function
in the targeting process of PMPs. Further, the complex of
PMP70 or other PMPs with Pex19p seems to be kept in import
competent state. We previously showed PMP70 translated in a
rabbit reticulocyte lysate was recovered in the soluble fractions
and was inserted into isolated peroxisomal membranes by
cytosolic factor dependent manner [30]. We also found the
solubilized PMP70 complex with Pex19p retained the perox-
isomal insertion ability. PMP70 but not Pex19p in the complex
was inserted in rat liver peroxisomes in vitro (data not shown).
Previous observations have shown that 70–80% of PMP22
synthesized by in vitro translation are soluble in a rabbit
reticulocyte lysate, and detailed analysis revealed that PMP22
bound to either TCP1 ring complex (TRiC), the eukaryotic
homolog of GroEL, or a single 40 kDa polypeptide [39,40].
PMP22 bound to this 40 kDa protein was efficiently inserted
into peroxisomes [40]. The 40 kDa protein could be Pex19p
since we recently found Pex19p also efficiently associated with
PMP22 in our in vitro protein synthesis system [41].
Second, we tried to determine which regions of PMP70
were required to interact with Pex19p. We have demonstrated
that the NH2-terminal 61 amino acids (possibly NH2-terminal
20/30–61 amino acids) and regions of TMD5 and 6 were
required for the efficient binding to Pex19p from the following
observations. (1) The interaction of PMP70 with Pex19p was
markedly decreased by the truncation of the NH2-terminal 61
amino acids of PMP70 (Fig. 7). (2) COOH-terminal truncation
of TMD6 also reduced the interaction but further deletion of
TMD3–5 did not show additional reduction (Fig. 8). (3) The
chimera proteins that the NH2-terminal 61 amino acids as well
as TMD5 and 6 were fused with E. coli DHFR associated with
Pex19p (Fig. 9). (4) Molecular sizes of PMP70 translated in
our in vitro translation system suggest that some PMP70s could
be processed NH2-terminal 20–30 amino acids (Figs. 7B and
8B). This truncation did not affect our conclusion. Further,
under our experimental conditions, a single Pex19p bound to a
single PMP70, therefore Pex19p would bind at these two
points and the lack of either region leads to a decrease in the
interaction.
Recently, Rottensteiner et al. deduced amino acid sequence,
xxx[CFILTVW]xx[ACFILQVWY][CILV]xx[ACFILV-
WY][ILQRV]xxx as the common Pex19p binding motif in
PMPs. They also suggested that the Pex19p binding sites of
Pex13p and Pex11p are an essential part of the mPTS and the
Pex19p binding sites in conjunction with one or more adjacent
TMDs are sufficient for peroxisomal targeting and insertion of
Pex13p in yeast cells [42]. We screened human PMP70
sequence against the predicted Pex19p binding motif andfound eight regions corresponded to the motif. Among them,
three sites were found in TMD5–6 and were overlapped with
one of the Pex19p binding sites we found, but none of these
sites were found in NH2-terminal 61 amino acids region,
another Pex19p binding site.
The Pex19p binding regions at NH2-terminal 61 amino
acids and TMD5 and 6 were also important for the targeting of
PMP70. From the immunofluorescence study, GFP fusion
proteins lacking either these two regions, as in PMP70
(AA.62–659)-GFP and PMP70 (AA.1–271)-GFP, did not
show any peroxisomal localization (Fig. 11B). In some PMPs,
the Pex19p binding sites are suggested to be overlapped with
their targeting elements and Pex19p is thought to function as
the targeting signal receptor of PMPs [18,23,35,43]. The above
findings might support that these regions in PMP70 are
included in their targeting element. However, we found the
candidate for the targeting element of PMP70 that was distinct
from the Pex19p binding sites at NH2-terminal 61 amino acids
and around TMD 5 and 6 by the following observations. To
identify the targeting element of PMP70, we constructed
several COOH-terminal deletions of PMP70-GFP and per-
formed immunofluorescence study. PMP70 (AA.1–271)-GFP
lost its targeting ability as described above, but further COOH-
terminal deletions of PMP70-GFP, PMP70 (AA.1–183)-GFP
and PMP70 (AA.1–144)-GFP, reappeared the peroxisomal
localization. On the other hand, further deletion construct,
PMP70 (AA.1–122)-GFP lost its targeting again (Fig. 11C).
These results suggest that the targeting signal of PMP70 is
located around TMD2, PMP70 (AA.123–144), and different
from the Pex19p binding sites. Concerning the reappearance of
peroxisomal localization after deletion of TMD 4–6, we
assume a following possibility. PMP70 (AA.1–271) lacking
TMD 5–6 did not keep it in suitable conformation for targeting
since the region lacked is important for the efficient binding to
Pex19p. On the other hand, in the cases of PMP70 (AA.1–183)
and PMP70 (AA.1–144), they possess only two or three TMDs
and become more hydrophilic than PMP70 (AA.1–271). It
might be able to keep them in suitable conformations for the
targeting although they possess only one Pex19p binding site at
the NH2-terminal 61 amino acids.
Sacksteder et al. also obtained the similar evidence that
PMP70 (AA.1–183)-myc and PMP70 (AA.1–124)-myc tar-
geted to peroxisomes but PMP70 (AA.1–101) mis-targeted to
mitochondria [23]. Recently Biemanns and Ga¨rtner have
demonstrated that efficient peroxisomal targeting of PMP70
is depend on NH2-terminal 61–160 amino acids including
TMD1 and 2 using NH2-terminal GFP fused PMP70. In their
experiment, the construct lacking NH2-terminal 60 amino acids
still targeted to peroxisomes [44]. Around TMD2, there is the
positively charged basic amino acid cluster resembling the
peroxisomal targeting motif of other PMPs [45–47]. These
results suggest that Pex19p is not likely to function as the
specific receptor for the targeting signal of PMP70. Recently,
Gould and coworkers proposed a model that Pex19p functions
both as a cytosolic chaperone and targeting signal receptor for
newly synthesized PMPs, and Pex19p directs them to the
peroxisomal membrane via binding to Pex3p [35,48].
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our data is in good accordance with the model and Pex19p
contributed to keep PMP70 in a soluble and suitable
conformation for targeting. However, our data were inconsis-
tent with the model in that Pex19p interact with PMP70 at the
region distinct from its targeting signal. Snyder et al. also
suggested Pex19p binding sites do not overlap with the
targeting signals of PMPs [24]. Furthermore, Fransen et al.
recently demonstrated that a mutant of Pex13p that failed to
bind to Pex19p, but targeted to peroxisomes [49]. Pex19p is a
highly acidic protein and possesses the property to interact with
polypeptides both at the hydrophobic regions and the positively
charged cluster(s). The specificity of the interaction seems to
depend on its physical properties. The interaction is not
preferential to peroxisomal targeting signals since physiolog-
ical importance about the interaction between Pex19p and non-
peroxisomal proteins such as Type IIa Na/Pi co-transporter [50]
and p19ARF [51] was shown recently.
Recent studies demonstrated Pex19p associates with 13
PMPs including PMP70 using yeast two-hybrid system, co-
immunoprecipitation, ligand blotting, and fluorescence reso-
nance transfer [23–26,43,52–54]. In the case of PMP70,
Pex19p has been demonstrated to interact with full-length
PMP70 as well as myc-PMP70 (AA.1–180, 61–160, 81–
160), but no quantitative analysis has not yet been performed
[26,44].
Based on our results, we propose a hypothetical model for the
targeting of PMP70. In the cytosol, Pex19p interacts with
PMP70 co-translationally at the NH2-terminal 61 amino acid
region and TMD5 and 6 and keeps it in soluble and proper
conformation for targeting. This solubilized PMP70 is then
targeted to peroxisomes by its own peroxisome targeting signal
located near the TMD2 including a positively charged basic
amino acid cluster, and integrated into the peroxisomal
membrane by the peroxisomal membrane insertion mechanism.
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